Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Epidemiological trends for childhood and adolescent cancers in the period 1994- 2016 in the Czech Republic [Epidemiologické trendy onkologických onemocnění u dětí a adolescentů v období 1994- 2016 v České Republice]

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F19%3A10410375" target="_blank" >RIV/00064203:_____/19:10410375 - isvavai.cz</a>

  • Nalezeny alternativní kódy

    RIV/00216208:11130/19:10410375

  • Výsledek na webu

    <a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=BpbRNPmtoA" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=BpbRNPmtoA</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.14735/amko2019426" target="_blank" >10.14735/amko2019426</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Epidemiological trends for childhood and adolescent cancers in the period 1994- 2016 in the Czech Republic [Epidemiologické trendy onkologických onemocnění u dětí a adolescentů v období 1994- 2016 v České Republice]

  • Popis výsledku v původním jazyce

    Background: Our study aimed to evaluate incidence and mortality trends for childhood and adolescent cancers in the period 1994- 2016 in the Czech Republic. Material and methods: Data on childhood cancers, which are recorded in the Czech National Cancer Registry, were validated using a clinical database of childhood cancer patients and combined with data from the National Register of Hospitalised Patients and with data from death certificates. These validated data were used to establish cancer incidence. Data from death certificates were used to evaluate long-term trends in mortality. Incidence and mortality trends were assessed by the average annual percentage change. Results: The age-standardised incidence trend for childhood cancers (i.e. those diagnosed in patients aged 0- 19 years) showed a statistically significant slight long-term increase in the number of new cases, +0.5% annually on average (p &lt; 0.01), more specifically an increase of +0.6% in girls and a statistically insignificant decrease of -0.1% in boys. In children aged 0- 14 years, other malignant epithelial neoplasms and malignant melanomas showed the largest statistically significant average annual increase in incidence (+4.9%; p &lt; 0.01), followed by central nervous system neoplasms (+1.3%; p &lt; 0.05). Lymphomas, by contrast, showed a statistically significant average annual decrease in incidence in children aged 0- 14 years (-2.1%; p &lt;0.01). In adolescents aged 15- 19 years, other malignant epithelial neoplasms and malignant melanomas also showed a statistically significant average annual increase in incidence (+5.2%; p &lt; 0.01), followed by central nervous system neoplasms (+1.5%; p &lt; 0.05). Mortality trends showed a statistically significant long-term decrease: On average, -5.1% annually in children aged 0- 14 years (p &lt; 0.01), and -3.7% annually in adolescents aged 15- 19 years (p &lt; 0.01). Conclusion: Available data make it possible to analyselong-term trends in childhood cancer incidence and mortality.

  • Název v anglickém jazyce

    Epidemiological trends for childhood and adolescent cancers in the period 1994- 2016 in the Czech Republic [Epidemiologické trendy onkologických onemocnění u dětí a adolescentů v období 1994- 2016 v České Republice]

  • Popis výsledku anglicky

    Background: Our study aimed to evaluate incidence and mortality trends for childhood and adolescent cancers in the period 1994- 2016 in the Czech Republic. Material and methods: Data on childhood cancers, which are recorded in the Czech National Cancer Registry, were validated using a clinical database of childhood cancer patients and combined with data from the National Register of Hospitalised Patients and with data from death certificates. These validated data were used to establish cancer incidence. Data from death certificates were used to evaluate long-term trends in mortality. Incidence and mortality trends were assessed by the average annual percentage change. Results: The age-standardised incidence trend for childhood cancers (i.e. those diagnosed in patients aged 0- 19 years) showed a statistically significant slight long-term increase in the number of new cases, +0.5% annually on average (p &lt; 0.01), more specifically an increase of +0.6% in girls and a statistically insignificant decrease of -0.1% in boys. In children aged 0- 14 years, other malignant epithelial neoplasms and malignant melanomas showed the largest statistically significant average annual increase in incidence (+4.9%; p &lt; 0.01), followed by central nervous system neoplasms (+1.3%; p &lt; 0.05). Lymphomas, by contrast, showed a statistically significant average annual decrease in incidence in children aged 0- 14 years (-2.1%; p &lt;0.01). In adolescents aged 15- 19 years, other malignant epithelial neoplasms and malignant melanomas also showed a statistically significant average annual increase in incidence (+5.2%; p &lt; 0.01), followed by central nervous system neoplasms (+1.5%; p &lt; 0.05). Mortality trends showed a statistically significant long-term decrease: On average, -5.1% annually in children aged 0- 14 years (p &lt; 0.01), and -3.7% annually in adolescents aged 15- 19 years (p &lt; 0.01). Conclusion: Available data make it possible to analyselong-term trends in childhood cancer incidence and mortality.

Klasifikace

  • Druh

    J<sub>SC</sub> - Článek v periodiku v databázi SCOPUS

  • CEP obor

  • OECD FORD obor

    30204 - Oncology

Návaznosti výsledku

  • Projekt

  • Návaznosti

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Ostatní

  • Rok uplatnění

    2019

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    Klinická onkologie

  • ISSN

    0862-495X

  • e-ISSN

  • Svazek periodika

    32

  • Číslo periodika v rámci svazku

    6

  • Stát vydavatele periodika

    CZ - Česká republika

  • Počet stran výsledku

    10

  • Strana od-do

    426-435

  • Kód UT WoS článku

  • EID výsledku v databázi Scopus

    2-s2.0-85076689106